Assertio Holdings, Inc. Acquisition Update: What You Need to Know

If you follow Assertio Holdings (ASRT), there is major news: the company is being acquired. Here is a plain-English breakdown of what this means for your investment.

1. The Deal at a Glance

Assertio Holdings announced it is being acquired by Garda Therapeutics, Inc. Here is the breakdown of the payout:

• Cash Payment: Garda will pay $18.00 per share in cash.
• Potential Bonus (CVR): You may also receive a "contingent value right" (CVR). This is a potential extra $2.50 per share if Assertio’s lead cancer drug hits specific FDA approval or sales milestones within 24 months.

2. Timeline

• Tender Offer: Garda plans to begin the process of buying your shares on April 29, 2026.
• Expected Closing: The deal is expected to close in the third quarter of 2026, assuming it passes regulatory reviews and enough shareholders agree to the sale.

3. Why the Board Agreed

Assertio began a formal search for potential buyers on April 8, 2026. After reviewing multiple bids, the board determined that Garda’s offer provided the best value for shareholders and has unanimously recommended that you tender (sell) your shares.

4. What This Means for Your Stock

• The Price Ceiling: Once a deal like this is announced, the stock price typically stops moving based on company performance and instead hovers just below the offer price ($18.00). It is unlikely to rise significantly higher unless a competing bidder emerges, which is less common after a formal search process.
• The Payout: If you hold shares, you can sell them to Garda during the tender offer. If you choose not to, your shares will likely be cashed out at the same $18.00 price during the final merger step.

5. Key Next Steps for Investors

• Watch for the Schedule 14D-9: When the offer officially begins on April 29, Assertio will file a document called a "Schedule 14D-9" with the SEC. This is the most important document for you to read, as it details the board’s reasoning and the specific legal terms of the CVR bonus. You can find this on the SEC website or the "Investor Relations" section of Assertio’s website.
• Manage Your Expectations: These deals are subject to antitrust reviews and other regulatory hurdles. Do not expect an immediate payout; the process typically takes 90 to 120 days to finalize.
• Consider Your Strategy: You now have to decide whether you want to hold your shares until the deal closes or sell them now on the open market to lock in your gains immediately.

Disclaimer: I am an AI, not a financial advisor. This summary is for informational purposes only and is not professional investment advice. Mergers involve risks, including the possibility that a deal could fall through. Always do your own research or consult with a qualified professional before making financial decisions.